Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             62 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormal N-linked glycosylation of cortical AMPA receptor subunits in schizophrenia Tucholski, Janusz
2013
146 1-3 p. 177-183
7 p.
artikel
2 Adherence therapy following an acute episode of schizophrenia: A multi-centre randomised controlled trial Schulz, Michael
2013
146 1-3 p. 59-63
5 p.
artikel
3 Angry affect and violence in the context of a psychotic illness: A systematic review and meta-analysis of the literature Reagu, Shuja
2013
146 1-3 p. 46-52
7 p.
artikel
4 Antipsychotic treatment dosing profile in patients with schizophrenia evaluated with electronic monitoring (MEMS®) Acosta, Francisco J.
2013
146 1-3 p. 196-200
5 p.
artikel
5 Antismoking and potential antipsychotic effects of varenicline in subjects with schizophrenia or schizoaffective disorder: A double-blind placebo and bupropion-controlled study Fatemi, S. Hossein
2013
146 1-3 p. 376-378
3 p.
artikel
6 Association of formal thought disorder in schizophrenia with structural brain abnormalities in language-related cortical regions Sans-Sansa, B.
2013
146 1-3 p. 308-313
6 p.
artikel
7 Attenuated cortisol response to acute psychosocial stress in individuals at ultra-high risk for psychosis Pruessner, Marita
2013
146 1-3 p. 79-86
8 p.
artikel
8 Atypical antipsychotics and effects of adrenergic and serotonergic receptor binding on insulin secretion in-vivo: An animal model Guenette, Melanie Dawn
2013
146 1-3 p. 162-169
8 p.
artikel
9 Cardiovascular mortality in schizophrenia: Defining a critical period for prevention Srihari, Vinod H.
2013
146 1-3 p. 64-68
5 p.
artikel
10 Change in neuropsychological functioning over one year in youth at clinical high risk for psychosis Woodberry, Kristen A.
2013
146 1-3 p. 87-94
8 p.
artikel
11 Childhood cat bites and disorganized symptoms of schizotypy in adulthood Kolpakova, J.
2013
146 1-3 p. 370-371
2 p.
artikel
12 Cholinergic muscarinic M4 receptor gene polymorphisms: A potential risk factor and pharmacogenomic marker for schizophrenia Scarr, Elizabeth
2013
146 1-3 p. 279-284
6 p.
artikel
13 Clinical symptoms, mainly negative symptoms, mediate the influence of neurocognition and social cognition on functional outcome of schizophrenia Lin, Chieh-Hsin
2013
146 1-3 p. 231-237
7 p.
artikel
14 Comprehensive analysis of copy number variation in monozygotic twins discordant for bipolar disorder or schizophrenia Bloom, Rachael J.
2013
146 1-3 p. 289-290
2 p.
artikel
15 Coping strategies in carers of young people with a first episode of psychosis Cotton, S.M.
2013
146 1-3 p. 118-124
7 p.
artikel
16 Delusions of body image in the prodrome Smith, Ashley K.
2013
146 1-3 p. 366-367
2 p.
artikel
17 Demand and modality of directed attention modulate “pre-attentive” sensory processes in schizophrenia patients and nonpsychiatric controls Rissling, Anthony J.
2013
146 1-3 p. 326-335
10 p.
artikel
18 Differences in developmental changes in academic and social premorbid adjustment between males and females with schizophrenia Allen, Daniel N.
2013
146 1-3 p. 132-137
6 p.
artikel
19 Disruption of function–structure coupling in brain regions sub-serving self monitoring in schizophrenia Araki, Tsuyoshi
2013
146 1-3 p. 336-343
8 p.
artikel
20 Early and late stages of visual processing in individuals in prodromal state and first episode schizophrenia: An ERP study Oribe, Naoya
2013
146 1-3 p. 95-102
8 p.
artikel
21 Early psychosis and employment Drake, Robert E.
2013
146 1-3 p. 111-117
7 p.
artikel
22 Editorial Board 2013
146 1-3 p. IFC-
1 p.
artikel
23 Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: Results from a randomized controlled trial Stroup, T. Scott
2013
146 1-3 p. 190-195
6 p.
artikel
24 Erratum to "Adherence to antipsychotic drug treatment in early-episode schizophrenia: A six- month naturalistic follow-up study” [Schizophrenia Research, 130 (2011), 176-181] Baloush-Kleinman, V.
2013
146 1-3 p. 379-
1 p.
artikel
25 Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia Burton, Cynthia Z.
2013
146 1-3 p. 244-248
5 p.
artikel
26 Frontal cortical synaptic communication is abnormal in Disc1 genetic mouse models of schizophrenia Holley, Sandra M.
2013
146 1-3 p. 264-272
9 p.
artikel
27 Genetic variation in BDNF is associated with antipsychotic treatment resistance in patients with schizophrenia Zhang, Jian-Ping
2013
146 1-3 p. 285-288
4 p.
artikel
28 Has the prevalence, clinical presentation and social functioning of schizophrenia changed over the last 25years? Nithsdale schizophrenia survey revisited Shivashankar, Somashekara
2013
146 1-3 p. 349-356
8 p.
artikel
29 Impaired processing of binaural temporal cues to auditory scene analysis in schizophrenia Matthews, Natasha
2013
146 1-3 p. 344-348
5 p.
artikel
30 Improving social perception in schizophrenia: The role of oxytocin Fischer-Shofty, M.
2013
146 1-3 p. 357-362
6 p.
artikel
31 Increasing mortality gap for patients diagnosed with schizophrenia over the last three decades — A Danish nationwide study from 1980 to 2010 Nielsen, René Ernst
2013
146 1-3 p. 22-27
6 p.
artikel
32 Indications for electroconvulsive treatment in schizophrenia: A systematic review Pompili, Maurizio
2013
146 1-3 p. 1-9
9 p.
artikel
33 Interview-based assessment of cognition in schizophrenia: Applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care Vita, Antonio
2013
146 1-3 p. 217-223
7 p.
artikel
34 IQ change over time in schizophrenia and healthy individuals: A meta-analysis Hedman, Anna M.
2013
146 1-3 p. 201-208
8 p.
artikel
35 Metabotropic glutamate receptor 5 binding and protein expression in schizophrenia and following antipsychotic drug treatment Matosin, Natalie
2013
146 1-3 p. 170-176
7 p.
artikel
36 Microstructural white matter alterations in psychotic disorder: A family-based diffusion tensor imaging study Domen, Patrick A.E.
2013
146 1-3 p. 291-300
10 p.
artikel
37 No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia Li, Jie
2013
146 1-3 p. 40-45
6 p.
artikel
38 No evidence of exogenous origin for the abnormal glutathione redox state in schizophrenia Ballesteros, Alejandro
2013
146 1-3 p. 184-189
6 p.
artikel
39 Peripheral vasopressin but not oxytocin relates to severity of acute psychosis in women with acutely-ill untreated first-episode psychosis Rubin, Leah H.
2013
146 1-3 p. 138-143
6 p.
artikel
40 Pharmacokinetic–pharmacodynamic modeling of antipsychotic drugs in patients with schizophrenia Part I: The use of PANSS total score and clinical utility Pilla Reddy, Venkatesh
2013
146 1-3 p. 144-152
9 p.
artikel
41 Pharmacokinetic–pharmacodynamic modelling of antipsychotic drugs in patients with schizophrenia: Part II: The use of subscales of the PANSS score Pilla Reddy, Venkatesh
2013
146 1-3 p. 153-161
9 p.
artikel
42 Pituitary volume in schizophrenia spectrum disorders Romo-Nava, F.
2013
146 1-3 p. 301-307
7 p.
artikel
43 Potential molecular mechanisms for decreased synaptic glutamate release in dysbindin-1 mutant mice Saggu, Shalini
2013
146 1-3 p. 254-263
10 p.
artikel
44 Predictors of substance use disorder treatment outcomes among patients with psychotic disorders Boden, Matthew Tyler
2013
146 1-3 p. 28-33
6 p.
artikel
45 Premorbid impairments in early-onset psychosis: Differences between patients with schizophrenia and bipolar disorder Payá, Beatriz
2013
146 1-3 p. 103-110
8 p.
artikel
46 Psychiatric symptom versus neurocognitive correlates of diminished expressivity in schizophrenia and mood disorders Cohen, Alex S.
2013
146 1-3 p. 249-253
5 p.
artikel
47 Randomized crossover study of the histamine H3 inverse agonist MK-0249 for the treatment of cognitive impairment in patients with schizophrenia F. Egan, Michael
2013
146 1-3 p. 224-230
7 p.
artikel
48 Reduction of cortical GABAergic inhibition correlates with working memory impairment in recent onset schizophrenia Takahashi, Shun
2013
146 1-3 p. 238-243
6 p.
artikel
49 Reimagining psychoses: An agnostic approach to diagnosis Keshavan, Matcheri S.
2013
146 1-3 p. 10-16
7 p.
artikel
50 Reproducibility of brain activation during auditory verbal hallucinations Diederen, K.M.J.
2013
146 1-3 p. 320-325
6 p.
artikel
51 Screening for substance use disorders in first-episode psychosis: Implications for readmission Batalla, Albert
2013
146 1-3 p. 125-131
7 p.
artikel
52 Sensitivity of individual items of the Positive and Negative Syndrome Scale (PANSS) and items subgroups to differentiate between placebo and drug treatment in schizophrenia Kozielska, Magdalena
2013
146 1-3 p. 53-58
6 p.
artikel
53 Sensory processing, neurocognition, and social cognition in schizophrenia: Towards a cohesive cognitive model de Jong, J. (Sjakko) J.
2013
146 1-3 p. 209-216
8 p.
artikel
54 Social dysfunction in schizophrenia: An investigation of the GAF scale's sensitivity to deficits in social cognition Robertson, Deirdre A.
2013
146 1-3 p. 363-365
3 p.
artikel
55 The association between rare large duplication of 16p11.2 and schizophrenia in the Singaporean Chinese population Zheng, Xuebin
2013
146 1-3 p. 368-369
2 p.
artikel
56 The auditory dorsal stream plays a crucial role in projecting hallucinated voices into external space Looijestijn, Jasper
2013
146 1-3 p. 314-319
6 p.
artikel
57 The regulation of gene expression involved in TGF-β signaling by ZNF804A, a risk gene for schizophrenia Umeda-Yano, Satomi
2013
146 1-3 p. 273-278
6 p.
artikel
58 The Schizophrenia Proneness Instrument, Child and Youth version (SPI-CY): Practicability and discriminative validity Fux, Lucien
2013
146 1-3 p. 69-78
10 p.
artikel
59 The special treatment of first rank auditory hallucinations and bizarre delusions in the diagnosis of schizophrenia Shinn, Ann K.
2013
146 1-3 p. 17-21
5 p.
artikel
60 Transcranial direct current stimulation (tDCS) for catatonic schizophrenia: A case study Shiozawa, Pedro
2013
146 1-3 p. 374-375
2 p.
artikel
61 Transcranial random noise stimulation for the treatment of negative symptoms in schizophrenia Palm, Ulrich
2013
146 1-3 p. 372-373
2 p.
artikel
62 Validation of the Taiwanese Mandarin version of the Personal and Social Performance scale in a sample of 655 stable schizophrenic patients Wu, Bo-Jian
2013
146 1-3 p. 34-39
6 p.
artikel
                             62 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland